Clinical Trials Logo

Clinical Trial Summary

This international, multi-center, multi-modal and prospective observational study aims to determine the phenotypic spectrum and the natural progression of the RFC1 repeat expansion disease, and to seek and validate digital, imaging, and molecular biomarkers that aid in diagnosis and serve as outcome measures in future clinical trials of this novel, but frequent ataxia with late adult-onset.

Clinical Trial Description

The investigators will perform an international, multi-center, multi-modal, and registry-based standardized prospective Natural History Study (NHS) in RFC1 repeat expansion disease. Participants will be assessed annually. Study visits with a standardized clinical examination will apply several clinical rating scales, and data will be entered into a clinical database (ARCA Registry; customized to the requirements of this specific study. At all study visits, patients will be asked to donate biosamples; biomaterial collection is optional, and participants can elect to participate in sampling of blood, urine, CSF, and/or a skin biopsy. Optionally, and depending on local availability at each participating site, additional examinations may be performed including imaging, quantitative movement and speech analysis, vestibular testing, a neuropsychological examination, or examination of swallowing function, all to fully capture the multisystemic presentation of the RFC1 repeat expansion disease. This study will delineate variable phenotypes of this relatively novel disease, and systematically characterize the longitudinal progression of multi-model biomarkers to determine the most sensitive, comprehensive, and reliable outcomes measures for future therapeutic trials. Here, longitudinal validation of targeted fluid biomarker candidates will be an important part. The multi-modal longitudinal design of the study and its comprehensive assessment will also provide mechanistic insights into the multisystemic evolution of the disease, which will especially allow to track and understand selective as well as overlapping dysfunction of the cerebellum, sensory peripheral nerves, the vestibular system, and additional systems known to be involved in RFC1 disease or 'CANVAS' as its related syndrome. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05177809
Study type Observational [Patient Registry]
Source University Hospital Tuebingen
Contact Matthis Synofzik, Prof. Dr.
Phone +49 7071 29
Email [email protected]
Status Recruiting
Start date December 14, 2021
Completion date December 2025

See also
  Status Clinical Trial Phase
Completed NCT03722212 - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test N/A
Terminated NCT03645265 - Rhythmic Entrainment in Bilingual Speakers With Dysarthria N/A
Recruiting NCT05125666 - Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection Phase 2
Recruiting NCT03881930 - Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy N/A
Completed NCT00950196 - Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia Phase 4
Completed NCT04183647 - Investigation of Acute Effects of Local Vibration and Whole-Body Vibration Applications N/A
Completed NCT03745248 - Aerobic Exercise, Balance Training, and Ataxia N/A
Recruiting NCT04099914 - Validation of a Clinical Algorithm for the Diagnosis of Recessive Ataxias
Recruiting NCT03945682 - The ASsessment and Physiotherapy managEment of Ataxia in Children Following Surgical Resection of Posterior Fossa Tumour N/A
Completed NCT01428544 - Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) N/A
Completed NCT00001324 - PET Scan to Study Brain Control of Human Movement
Completed NCT00244361 - Effectiveness of Rituximab in Pediatric OMS Patients. Phase 1/Phase 2
Completed NCT00692861 - Autoimmunity in Neurologic Complications of Celiac Disease
Recruiting NCT02841553 - Wolfram Syndrome International Registry and Clinical Study
Active, not recruiting NCT02829268 - A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome Phase 1/Phase 2
Completed NCT02977377 - The Effects Of Whole Body Vibration On Postural Control In Patients With Ataxia N/A
Completed NCT01428531 - Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment N/A
Completed NCT03701776 - Ataxia and Exercise Disease Using MRI and Gait Analysis N/A
Recruiting NCT02400528 - Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families N/A
Completed NCT00272272 - Fall Prevention in a Geriatric Nursing Home Setting Using the Music of Nolwenn Leroy N/A